Clinical Trials Browser

Phase 2 × INDUSTRY × brivanib × Clear all

NCT00355238 2023-12-01

A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer

Phase 2 Completed

137 enrolled 20 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00633789 2015-10-09

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Phase 2 Completed

GastrointestinalGenitourinarySarcoma

Adenocarcinoma Of Esophagus, Carcinoma, Transitional Cell, Sarcoma